Ji-Young Lee Selected Research

Infections

1/2023	Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus.
1/2023	Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation.
1/2022	A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo.
11/2020	Rubi Fructus Water Extract Alleviates LPS-Stimulated Macrophage Activation via an ER Stress-Induced Calcium/CHOP Signaling Pathway.
6/2018	Colistin resistance in Enterobacter spp. isolates in Korea.
1/2018	Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes.
6/2017	Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
1/2017	Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity.
1/2016	Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji-Young Lee Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 04/2002
31	Inflammation (Inflammations) 03/2024 - 07/2014
15	Obesity 05/2022 - 06/2011
11	Breast Neoplasms (Breast Cancer) 11/2021 - 03/2008
10	Liver Cirrhosis (Hepatic Cirrhosis) 02/2022 - 01/2019
9	Infections 01/2023 - 01/2016
9	Non-alcoholic Fatty Liver Disease 05/2022 - 04/2011
8	Hypoxia (Hypoxemia) 03/2024 - 03/2008
8	Atherosclerosis 07/2022 - 08/2008
6	Insulin Resistance 07/2022 - 01/2007
6	Fibrosis (Cirrhosis) 05/2022 - 01/2017
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2007
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2015
5	Graves Ophthalmopathy 01/2021 - 01/2016
5	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 07/2004
4	Carcinoma (Carcinomatosis) 11/2023 - 10/2004
4	Body Weight (Weight, Body) 01/2022 - 12/2018
4	Stroke (Strokes) 01/2022 - 12/2012
4	Fatty Liver 11/2020 - 06/2015
3	Hypertension (High Blood Pressure) 09/2018 - 12/2007
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 05/2011
3	Ovarian Neoplasms (Ovarian Cancer) 04/2015 - 04/2006
2	COVID-19 04/2024 - 12/2022
2	Eosinophilia-Myalgia Syndrome 04/2024 - 08/2023
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 09/2006
2	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2005
2	Virus Diseases (Viral Diseases) 01/2023 - 01/2023
2	Neuroinflammatory Diseases 10/2022 - 07/2022
2	Central Serous Chorioretinopathy 01/2022 - 09/2021
2	Alcoholic Fatty Liver 01/2022 - 11/2021
2	Glucose Intolerance 01/2022 - 01/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 09/2011

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2002
13	CholesterolIBA 07/2022 - 05/2011
13	LipidsIBA 05/2022 - 03/2008
12	Biomarkers (Surrogate Marker)IBA 10/2023 - 04/2015
9	AntioxidantsIBA 01/2022 - 04/2011
8	Apolipoproteins E (ApoE)IBA 01/2023 - 05/2011
8	CytokinesIBA 12/2022 - 06/2015
8	ApolipoproteinsIBA 07/2022 - 09/2011
7	astaxanthine (astaxanthin)IBA 02/2022 - 12/2014
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2004
5	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 04/2011
5	Ethanol (Ethyl Alcohol)IBA 01/2022 - 11/2020
5	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 06/2006
4	Histones (Histone)IBA 03/2024 - 04/2006
4	Insulin (Novolin)FDA Link 03/2024 - 05/2011
4	Messenger RNA (mRNA)IBA 05/2022 - 02/2014
4	fucoxanthinIBA 05/2022 - 06/2019
4	Extracellular Matrix ProteinsIBA 02/2022 - 01/2019
4	Carotenoids (Carotene)IBA 02/2022 - 01/2017
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 05/2011
4	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2019
4	Progesterone Receptors (Progesterone Receptor)IBA 11/2021 - 07/2008
4	Troleandomycin (TAO)FDA Link 01/2021 - 01/2016
4	Sirtuin 1IBA 01/2021 - 04/2016
4	Hormones (Hormone)IBA 08/2017 - 12/2011
4	Estrogens (Estrogen)FDA Link 04/2015 - 07/2008
3	Tryptophan (L-Tryptophan)FDA Link 04/2024 - 10/2020
3	ErbB Receptors (EGF Receptor)IBA 04/2024 - 03/2012
3	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 06/2015
3	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2020
3	oxidized low density lipoproteinIBA 07/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2011
3	nicotinamide-beta-ribosideIBA 01/2022 - 01/2019
3	Therapeutic UsesIBA 01/2022 - 01/2018
3	Estrogen ReceptorsIBA 11/2021 - 11/2010
3	LipopolysaccharidesIBA 09/2021 - 04/2019
3	Sucrose (Saccharose)IBA 06/2021 - 04/2016
3	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021 - 08/2020
3	NAD (NADH)IBA 01/2021 - 04/2016
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 05/2005
3	ParaffinIBA 12/2020 - 11/2018
3	EnzymesIBA 10/2018 - 01/2016
3	HDL CholesterolIBA 09/2018 - 05/2011
3	Colistin (Coly-Mycin)FDA Link 06/2018 - 01/2016
3	TeaIBA 06/2015 - 04/2011
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2014 - 06/2011
2	VaccinesIBA 04/2024 - 11/2020
2	Transcription Factors (Transcription Factor)IBA 03/2024 - 09/2020
2	Small Interfering RNA (siRNA)IBA 01/2024 - 02/2014
2	Particulate MatterIBA 12/2023 - 01/2015
2	Cell-Free Nucleic AcidsIBA 10/2023 - 05/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 02/2014
2	LDL Receptors (LDL Receptor)IBA 07/2022 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 05/2022 - 06/2018
2	Interleukin-6 (Interleukin 6)IBA 04/2022 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 01/2018
2	Serine (L-Serine)FDA Link 01/2022 - 04/2015
2	human ERBB2 proteinIBA 11/2021 - 01/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 11/2021 - 01/2021
2	CollagenIBA 11/2021 - 11/2020
2	Anthocyanins (Anthocyanin)IBA 06/2021 - 12/2018
2	LeptinIBA 01/2021 - 05/2011
2	Formaldehyde (Formol)FDA Link 12/2020 - 11/2018
2	SirtuinsIBA 11/2020 - 04/2016
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2018
2	BilirubinIBA 01/2020 - 01/2019

Therapy/Procedure

20	Therapeutics 01/2024 - 10/2004
3	Immunotherapy 05/2021 - 09/2012